Glenmark signs agreement with Particle Sciences for generic ABRAXANE
Glenmark obtains global exclusive commercial marketing and distribution rights for the product
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon appoints Suresh Subramanian as Head of Branded Formulations (India) Business
Over 30 years of experience in the pharma market, he has worked with MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and…
Govt extends time frame of voluntary pharma marketing code
Earlier the government had plans to make voluntary UCPMP mandatory, now its implementation date has been extended until further…
OPPI’s HR Summit held in Mumbai
Discussions were held on the role of diversity and digitalisation in transforming the industry
The role of diversity and…
Natco to file over 10 ANDAs in US
The ANDAs will be filed in the next two financial years to expand its presence in the American market
Drug firm Natco Pharma is…
Marken expands presence in India
Marken establishes its Global Control Center and signs exclusive agreement with Jeena to accelerate business
DRL Laboratories collaborates with Amgen in India
DRL has expanded its strategic collaboration with Amgen
SEBI approves GreenSignal Bio Pharma for IPO
IPO consists of 38 per cent equity share capital
Glenmark obtains ANDA approval for diclofenac sodium gel
The company continues to identify and explore external development partnerships to supplement and accelerate the growth of its…
Ajanta Pharma gets US FDA approval for aripiprazole tabs
Aripiprazole tablets will be launched in the US soon